Reverie Labs
YC W18 · Inactive · Engineering next-generation, brain-penetrant cancer therapies.
Competitors
| Company | Category | Status | Program |
|---|---|---|---|
| AI | Acquired | SPC2018 | |
| Other | Active | YCS22 | |
| AI | Active | YCS23 | |
| AI | Active | YCW20 | |
| AI | Active | YCW18 |
Adjacent
| Company | Category | Status | Program |
|---|---|---|---|
| AI | Inactive | YCW19 | |
| AI | Active | YCS21 | |
| AI | Active | YCS22 | |
| Other | Active | YCS21 | |
| Other | Not stated | Plug and Play |
Also from W18 in AI
All of W18About Reverie Labs
Reverie Labs is engineering next-generation, brain-penetrant cancer therapies.
- YC batch
- W18 · Winter 2018
- Status, per YC
- Inactive
- Category
- AI
- Team size
- 29
- Location
- Boston, MA, USA; Cambridge, MA, USA
- Checked
- 36m ago
YC tags: AI-powered Drug Discovery, Machine Learning, Biotech
Reverie Labs: questions
Which YC batch was Reverie Labs in?
Reverie Labs was in Y Combinator's Winter 2018 batch (W18).
Is Reverie Labs still active?
Y Combinator lists Reverie Labs as inactive.
Where is Reverie Labs based?
Reverie Labs lists Boston, MA, USA; Cambridge, MA, USA as its location on YC's directory.
Sources: each program's public company list, read twice a week. Not affiliated with Y Combinator or any other program. Logos via logo.dev; trademarks belong to their owners.